Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
Arcturus Therapeutics (ARCT) - P/B ratio
P/B ratio as of April 2024 : 2.57
According to Arcturus Therapeutics
's latest financial reports the company has a price-to-book ratio of 2.57.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Arcturus Therapeutics - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.03 | 81.57% |
| 2022-12-31 | 1.67 | -61.03% |
| 2021-12-31 | 4.28 | 59.55% |
| 2020-12-31 | 2.68 | -58% |
| 2019-12-31 | 6.38 | 79.26% |
| 2018-12-31 | 3.56 | 43.15% |
| 2017-12-31 | 2.49 | -93.23% |
| 2016-12-31 | 36.7 | 1370.13% |
| 2015-12-31 | 2.50 | -2.59% |
| 2014-12-31 | 2.56 | -49.16% |
| 2013-12-31 | 5.04 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -346.53% | Bahamas |
 NRC Health
NRC | 16.7 | 549.91% | 🇺🇸 USA |